name,category,termsBRI3 binding protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
BRI3 binding protein,UP_SEQ_FEATURE[850008395$chain:BRI3-binding protein, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
Bardet-Biedl syndrome 1,OMIM_DISEASE[520000507$Bardet-Biedl syndrome 1]
Bardet-Biedl syndrome 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000168$Bardet-Biedl syndrome, 790000264$cell membrane, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001067$obesity, 790001162$phosphoprotein, 790001377$sensory transduction, 790001622$vision]
Bardet-Biedl syndrome 1,UP_SEQ_FEATURE[850007298$chain:Bardet-Biedl syndrome 1 protein, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
CMT1A duplicated region transcript 15,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
CMT1A duplicated region transcript 15,UP_SEQ_FEATURE[850011727$chain:CMT1A duplicated region transcript 15 protein, 850117294$sequence conflict, 850117295$sequence variant]
DNL-type zinc finger,INTERPRO[450007201$IPR007853:Zinc finger, Zim17-type]
DNL-type zinc finger,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
DNL-type zinc finger,UP_SEQ_FEATURE[850016210$chain:DNL-type zinc finger protein, 850117295$sequence variant, 850118804$zinc finger region:DNL-type]
G antigen 2A; G antigen 2B; G antigen 12I; G antigen 12F; G antigen 2E; G antigen 12G; G antigen 12D; G antigen 1; G antigen 2C; G antigen 12E; G antigen 2D; G antigen 12B; G antigen 3; G antigen 4; G antigen 12C; G antigen 5; G antigen 6; G antigen 7; G antigen 8,INTERPRO[450007883$IPR008625:GAGE]
G antigen 2A; G antigen 2B; G antigen 12I; G antigen 12F; G antigen 2E; G antigen 12G; G antigen 12D; G antigen 1; G antigen 2C; G antigen 12E; G antigen 2D; G antigen 12B; G antigen 3; G antigen 4; G antigen 12C; G antigen 5; G antigen 6; G antigen 7; G antigen 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
G antigen 2A; G antigen 2B; G antigen 12I; G antigen 12F; G antigen 2E; G antigen 12G; G antigen 12D; G antigen 1; G antigen 2C; G antigen 12E; G antigen 2D; G antigen 12B; G antigen 3; G antigen 4; G antigen 12C; G antigen 5; G antigen 6; G antigen 7; G antigen 8,UP_SEQ_FEATURE[850020211$chain:G antigen 1, 850020213$chain:G antigen 12C/D/E, 850020214$chain:G antigen 12F/G/I, 850020218$chain:G antigen 2A/2B, 850020219$chain:G antigen 3, 850020220$chain:G antigen 4, 850020221$chain:G antigen 5, 850020222$chain:G antigen 6, 850020223$chain:G antigen 7, 850020224$chain:G antigen 8, 850106258$modified residue, 850117294$sequence conflict]
GDNF family receptor alpha 3,INTERPRO[450003005$IPR003438:Glial cell line-derived neurotrophic factor receptor, 450003073$IPR003505:Glial cell line-derived neurotrophic factor receptor, alpha 3, 450014416$IPR016017:GDNF/GAS1]
GDNF family receptor alpha 3,PIR_SUPERFAMILY[630012048$PIRSF015163:Mus musculus GPI-linked receptor]
GDNF family receptor alpha 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001301$receptor, 790001405$signal]
GDNF family receptor alpha 3,UP_SEQ_FEATURE[850020729$chain:GDNF family receptor alpha-3, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105856$lipid moiety-binding region:GPI-anchor amidated asparagine, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
H2A histone family, member B1,INTERPRO[450001877$IPR002119:Histone H2A, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
H2A histone family, member B1,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
H2A histone family, member B1,SMART[760000361$SM00414:H2A]
H2A histone family, member B1,SP_PIR_KEYWORDS[790000315$chromosomal protein, 790000356$complete proteome, 790000466$dna-binding, 790001058$nucleosome core, 790001065$nucleus]
H2A histone family, member B1,UP_SEQ_FEATURE[850023990$chain:Histone H2A-Bbd type 1, 850111470$region of interest:Docking domain]
KIAA1305,INTERPRO[450001406$IPR001584:Integrase, catalytic core]
KIAA1305,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
KIAA1305,UP_SEQ_FEATURE[850026221$chain:Integrase catalytic domain-containing protein KIAA1305, 850104419$domain:Integrase catalytic, 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
KIAA1614,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
KIAA1614,UP_SEQ_FEATURE[850075556$chain:Uncharacterized protein KIAA1614, 850102597$compositionally biased region:Ser-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MIF4G domain containing,INTERPRO[450003415$IPR003890:MIF4G-like, type 3, 450014420$IPR016021:MIF4-like, type 1/2/3]
MIF4G domain containing,SMART[760000483$SM00543:MIF4G]
MIF4G domain containing,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001551$translation regulation]
MIF4G domain containing,UP_SEQ_FEATURE[850031734$chain:MIF4G domain-containing protein, 850104778$domain:MIF4G, 850118574$splice variant]
MYST histone acetyltransferase (monocytic leukemia) 4,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450002410$IPR002717:MOZ/SAS-like protein, 450005266$IPR005818:Histone H1/H5, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014522$IPR016181:Acyl-CoA N-acyltransferase, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
MYST histone acetyltransferase (monocytic leukemia) 4,SMART[760000221$SM00249:PHD, 760000466$SM00526:H15]
MYST histone acetyltransferase (monocytic leukemia) 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000025$Acyltransferase, 790000053$alternative splicing, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
MYST histone acetyltransferase (monocytic leukemia) 4,UP_SEQ_FEATURE[850023870$chain:Histone acetyltransferase MYST4, 850102562$compositionally biased region:Met-rich, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850111190$region of interest:Catalytic, 850112133$region of interest:Interaction with BRPF1, 850112798$region of interest:Interaction with RUNX1 and RUNX2, 850113734$region of interest:Negatively regulates HAT activity, 850117294$sequence conflict, 850117295$sequence variant, 850117914$site:Breakpoint for translocation to form MYST4-CREBBP, 850118574$splice variant, 850118743$zinc finger region:C2HC-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,INTERPRO[450008527$IPR009423:NADH:ubiquinone oxidoreductase, subunit b14.5b]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,PIR_SUPERFAMILY[630014491$PIRSF017834:NADH dehydrogenase [ubiquinone] (complex I), subunit C2, 630014492$PIRSF017834:NADH-UbQ_OxRdtase_b14.5b]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001555$transmembrane, 790001558$transport]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,UP_SEQ_FEATURE[850033542$chain:NADH dehydrogenase [ubiquinone] 1 subunit C2, 850106258$modified residue, 850117295$sequence variant, 850118623$transmembrane region]
Norrie disease (pseudoglioma),INTERPRO[450002690$IPR003064:Norrie disease protein, 450005633$IPR006207:Cystine knot, C-terminal]
Norrie disease (pseudoglioma),OMIM_DISEASE[520001837$Exudative vitreoretinopathy, X-linked, 520003684$Norrie disease]
Norrie disease (pseudoglioma),PIR_SUPERFAMILY[630014843$PIRSF018206:norrin]
Norrie disease (pseudoglioma),SMART[760000033$SM00041:CT]
Norrie disease (pseudoglioma),SP_PIR_KEYWORDS[790000356$complete proteome, 790000415$deafness, 790000446$disease mutation, 790000447$disulfide bond, 790001212$polymorphism, 790001363$Secreted, 790001377$sensory transduction, 790001405$signal, 790001622$vision, 790001642$wnt signaling pathway]
Norrie disease (pseudoglioma),UP_SEQ_FEATURE[850034724$chain:Norrin, 850102883$disulfide bond, 850103430$domain:CTCK, 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide]
RAR-related orphan receptor C,INTERPRO[450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450002705$IPR003079:Nuclear receptor ROR, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
RAR-related orphan receptor C,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
RAR-related orphan receptor C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
RAR-related orphan receptor C,UP_SEQ_FEATURE[850035040$chain:Nuclear receptor ROR-gamma, 850102570$compositionally biased region:Poly-Gln, 850102946$DNA-binding region:Nuclear receptor, 850111880$region of interest:Hinge, 850113269$region of interest:Ligand-binding, 850113461$region of interest:Modulating, 850118574$splice variant, 850118866$zinc finger region:NR C4-type]
RAS p21 protein activator 2,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001388$IPR001562:Zinc finger, Btk motif, 450001635$IPR001849:Pleckstrin homology, 450001714$IPR001936:Ras GTPase-activating protein, 450010818$IPR011993:Pleckstrin homology-type, 450016334$IPR018029:C2 membrane targeting protein]
RAS p21 protein activator 2,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
RAS p21 protein activator 2,SMART[760000094$SM00107:BTK, 760000205$SM00233:PH, 760000211$SM00239:C2, 760000292$SM00323:RasGAP]
RAS p21 protein activator 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
RAS p21 protein activator 2,UP_SEQ_FEATURE[850056684$chain:Ras GTPase-activating protein 2, 850102378$compositionally biased region:Ala-rich, 850103200$domain:C2 1, 850103201$domain:C2 2, 850104979$domain:PH, 850105148$domain:Ras-GAP, 850106258$modified residue, 850117294$sequence conflict, 850118652$zinc finger region:Btk-type]
RUN and SH3 domain containing 2,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450003532$IPR004012:RUN, 450010373$IPR011511:Variant SH3]
RUN and SH3 domain containing 2,SMART[760000295$SM00326:SH3, 760000527$SM00593:RUN]
RUN and SH3 domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
RUN and SH3 domain containing 2,UP_SEQ_FEATURE[850026732$chain:Iporin, 850102572$compositionally biased region:Poly-Glu, 850105223$domain:RUN, 850105350$domain:SH3, 850106258$modified residue, 850117295$sequence variant]
UDP glucuronosyltransferase 2 family, polypeptide B15,INTERPRO[450001963$IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase]
UDP glucuronosyltransferase 2 family, polypeptide B15,KEGG_PATHWAY[470038728$hsa00040:Pentose and glucuronate interconversions, 470038731$hsa00053:Ascorbate and aldarate metabolism, 470038739$hsa00140:Steroid hormone biosynthesis, 470038740$hsa00150:Androgen and estrogen metabolism, 470038765$hsa00500:Starch and sucrose metabolism, 470038801$hsa00830:Retinol metabolism, 470038802$hsa00860:Porphyrin and chlorophyll metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism, 470038810$hsa00983:Drug metabolism]
UDP glucuronosyltransferase 2 family, polypeptide B15,PIR_SUPERFAMILY[630005607$PIRSF005678:glucuronosyltransferase]
UDP glucuronosyltransferase 2 family, polypeptide B15,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000691$hexosyltransferase, 790000919$membrane, 790000959$microsome, 790001212$polymorphism, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
UDP glucuronosyltransferase 2 family, polypeptide B15,UP_SEQ_FEATURE[850068247$chain:UDP-glucuronosyltransferase 2B15, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118623$transmembrane region]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,INTERPRO[450000500$IPR000587:Creatinase, 450000865$IPR000994:Peptidase M24, structural domain, 450000992$IPR001131:Peptidase M24B, X-Pro dipeptidase/aminopeptidase P, conserved site]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,PIR_SUPERFAMILY[630006687$PIRSF006732:pig X-Pro aminopeptidase]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000069$Aminopeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000906$manganese, 790000937$metal-binding, 790000941$metalloprotease, 790001252$Protease]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,UP_SEQ_FEATURE[850100987$chain:Xaa-Pro aminopeptidase 1, 850105852$helix, 850106174$metal ion-binding site:Manganese 1, 850106177$metal ion-binding site:Manganese 2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
adhesion molecule with Ig-like domain 2,COG_ONTOLOGY[90000070$Function unknown]
adhesion molecule with Ig-like domain 2,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
adhesion molecule with Ig-like domain 2,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000357$SM00409:IG]
adhesion molecule with Ig-like domain 2,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001065$nucleus, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
adhesion molecule with Ig-like domain 2,UP_SEQ_FEATURE[850005153$chain:Amphoterin-induced protein 2, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
alkB, alkylation repair homolog 3 (E. coli),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000437$dioxygenase, 790000452$DNA damage, 790000459$dna repair, 790000802$iron, 790000937$metal-binding, 790001065$nucleus, 790001092$oxidoreductase, 790001212$polymorphism, 790001626$vitamin c]
alkB, alkylation repair homolog 3 (E. coli),UP_SEQ_FEATURE[850000225$binding site:Alpha-ketoglutarate, 850000555$binding site:Substrate, 850004814$chain:Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3, 850103759$domain:Fe2OG dioxygenase, 850105852$helix, 850106100$metal ion-binding site:Iron; catalytic, 850106259$mutagenesis site, 850110916$region of interest:Alpha-ketoglutarate binding, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118568$site:Susceptible to oxidation, 850118574$splice variant, 850118575$strand]
amidohydrolase domain containing 2,INTERPRO[450003305$IPR003764:N-acetylglucosamine-6-phosphate deacetylase, 450006091$IPR006680:Amidohydrolase 1, 450017991$IPR019756:Peptidase S26A, signal peptidase I, serine active site]
amidohydrolase domain containing 2,KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
amidohydrolase domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000743$hydrolase, 790001212$polymorphism]
amidohydrolase domain containing 2,UP_SEQ_FEATURE[850052807$chain:Putative N-acetylglucosamine-6-phosphate deacetylase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat domain 55,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 55,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 55,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat domain 55,UP_SEQ_FEATURE[850005409$chain:Ankyrin repeat domain-containing protein 55, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850115660$repeat:ANK 9, 850117295$sequence variant, 850118574$splice variant]
calcium/calmodulin-dependent protein kinase IV,BBID[10000006$103.Ca2-calmodulin_PK_cascade]
calcium/calmodulin-dependent protein kinase IV,BIOCARTA[30000043$h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation, 30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart), 30000226$h_pgc1aPathway:Regulation of PGC-1a, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents]
calcium/calmodulin-dependent protein kinase IV,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014168$IPR015733:Calcium/calmodulin-dependent protein kinase IV, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase IV,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway]
calcium/calmodulin-dependent protein kinase IV,OMIM_DISEASE[520001930$Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness]
calcium/calmodulin-dependent protein kinase IV,PIR_SUPERFAMILY[630000702$PIRSF000595:calcium/calmodulin-dependent protein kinase, type IV]
calcium/calmodulin-dependent protein kinase IV,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase IV,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000212$calcium binding, 790000217$calmodulin binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase IV,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009094$chain:Calcium/calmodulin-dependent protein kinase type IV, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850110972$region of interest:Autoinhibitory domain, 850111164$region of interest:Calmodulin-binding, 850117295$sequence variant, 850118575$strand, 850118624$turn]
casein kinase 1, gamma 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
casein kinase 1, gamma 1,KEGG_PATHWAY[470038849$hsa04340:Hedgehog signaling pathway]
casein kinase 1, gamma 1,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein, 630031202$PIRSF501113:casein kinase 1]
casein kinase 1, gamma 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
casein kinase 1, gamma 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009782$chain:Casein kinase I isoform gamma-1, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,BBID[10000004$101.Gprot_coupled_Rec_MAP_Kinase, 10000104$82.TCR_and_Cap_or_SMAC]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation, 30000055$h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration, 30000179$h_malPathway:Role of MAL in Rho-Mediated Activation of SRF, 30000215$h_p38mapkPathway:p38 MAPK Signaling Pathway , 30000255$h_rasPathway:Ras Signaling Pathway, 30000265$h_salmonellaPathway:How does salmonella hijack a cell]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,INTERPRO[450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038841$hsa04144:Endocytosis, 470038851$hsa04360:Axon guidance, 470038852$hsa04370:VEGF signaling pathway, 470038853$hsa04510:Focal adhesion, 470038856$hsa04520:Adherens junction, 470038857$hsa04530:Tight junction, 470038869$hsa04660:T cell receptor signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038873$hsa04670:Leukocyte transendothelial migration, 470038877$hsa04722:Neurotrophin signaling pathway, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038883$hsa04912:GnRH signaling pathway, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection, 470038898$hsa05130:Pathogenic Escherichia coli infection, 470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma, 470038902$hsa05212:Pancreatic cancer]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,PIR_SUPERFAMILY[630028684$PIRSF037169:small GTPase, Rho type, 630030779$PIRSF500582:cell division control protein 42]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,SMART[760000148$SM00174:RHO]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000260$cell division, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000637$GTP binding, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000952$methylated carboxyl end, 790000953$methylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001235$prenylated cysteine, 790001236$prenylation]
cell division cycle 42 (GTP binding protein, 25kDa); cell division cycle 42 pseudogene 2,UP_SEQ_FEATURE[850010330$chain:Cell division control protein 42 homolog, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117441$short sequence motif:Effector region, 850118574$splice variant, 850118575$strand, 850118624$turn]
chromosome 1 open reading frame 145,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 1 open reading frame 145,UP_SEQ_FEATURE[850073601$chain:Uncharacterized protein C1orf145, 850118574$splice variant]
chromosome 10 open reading frame 4,INTERPRO[450017375$IPR019129:Folate-sensitive fragile site protein Fra10Ac1]
chromosome 10 open reading frame 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 10 open reading frame 4,UP_SEQ_FEATURE[850046207$chain:Protein FRA10AC1, 850102554$compositionally biased region:Lys-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 16 open reading frame 53,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 16 open reading frame 53,UP_SEQ_FEATURE[850036954$chain:PAXIP1-associated protein 1, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue]
chromosome 17 open reading frame 45,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
chromosome 17 open reading frame 45,UP_SEQ_FEATURE[850055486$chain:Putative uncharacterized protein NCRNA00188, mitochondrial, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
chromosome 17 open reading frame 49,INTERPRO[450000876$IPR001005:SANT, DNA-binding]
chromosome 17 open reading frame 49,SMART[760000623$SM00717:SANT]
chromosome 17 open reading frame 49,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein]
chromosome 17 open reading frame 49,UP_SEQ_FEATURE[850032212$chain:MLL1/MLL complex subunit C17orf49, 850105254$domain:SANT, 850106258$modified residue]
chromosome 19 open reading frame 28,COG_ONTOLOGY[90000016$Carbohydrate transport and metabolism]
chromosome 19 open reading frame 28,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
chromosome 19 open reading frame 28,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
chromosome 19 open reading frame 28,UP_SEQ_FEATURE[850070795$chain:Uncharacterized MFS-type transporter C19orf28, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 6 open reading frame 47,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 6 open reading frame 47,UP_SEQ_FEATURE[850074374$chain:Uncharacterized protein C6orf47, 850106258$modified residue, 850117295$sequence variant]
coenzyme Q2 homolog, prenyltransferase (yeast),INTERPRO[450000460$IPR000537:UbiA prenyltransferase, 450005793$IPR006370:4-hydroxybenzoate polyprenyl transferase]
coenzyme Q2 homolog, prenyltransferase (yeast),KEGG_PATHWAY[470038738$hsa00130:Ubiquinone and other terpenoid-quinone biosynthesis]
coenzyme Q2 homolog, prenyltransferase (yeast),OMIM_DISEASE[520001070$Coenzyme Q10 deficiency]
coenzyme Q2 homolog, prenyltransferase (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000812$Isoprene biosynthesis, 790000919$membrane, 790000969$mitochondrion, 790001547$transferase, 790001550$transit peptide, 790001555$transmembrane, 790001590$ubiquinone biosynthesis]
coenzyme Q2 homolog, prenyltransferase (yeast),UP_SEQ_FEATURE[850036821$chain:Para-hydroxybenzoate-- polyprenyltransferase, mitochondrial, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region]
damage-specific DNA binding protein 2, 48kDa,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
damage-specific DNA binding protein 2, 48kDa,KEGG_PATHWAY[470038823$hsa03420:Nucleotide excision repair, 470038836$hsa04115:p53 signaling pathway, 470038837$hsa04120:Ubiquitin mediated proteolysis]
damage-specific DNA binding protein 2, 48kDa,OMIM_DISEASE[520005124$Xeroderma pigmentosum, group E, DDB-negative subtype]
damage-specific DNA binding protein 2, 48kDa,SMART[760000289$SM00320:WD40]
damage-specific DNA binding protein 2, 48kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001638$wd repeat, 790001643$xeroderma pigmentosum]
damage-specific DNA binding protein 2, 48kDa,UP_SEQ_FEATURE[850015526$chain:DNA damage-binding protein 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114335$region of interest:Required for interaction with DDB1, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117295$sequence variant, 850117429$short sequence motif:DWD box, 850118574$splice variant, 850118575$strand, 850118624$turn]
dynactin 2 (p50),INTERPRO[450006392$IPR006996:Dynamitin]
dynactin 2 (p50),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 2 (p50),SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000475$dynein, 790000919$membrane, 790000960$microtubule, 790001162$phosphoprotein]
dynactin 2 (p50),UP_SEQ_FEATURE[850016477$chain:Dynactin subunit 2, 850106258$modified residue, 850117294$sequence conflict]
eukaryotic translation elongation factor 1 epsilon 1,INTERPRO[450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
eukaryotic translation elongation factor 1 epsilon 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001255$protein biosynthesis]
eukaryotic translation elongation factor 1 epsilon 1,UP_SEQ_FEATURE[850018075$chain:Eukaryotic translation elongation factor 1 epsilon-1, 850104084$domain:GST C-terminal, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
exostoses (multiple) 1,INTERPRO[450003770$IPR004263:Exostosin-like, 450013780$IPR015338:EXTL2, alpha-1,4-N-acetylhexosaminyltransferase]
exostoses (multiple) 1,KEGG_PATHWAY[470038774$hsa00534:Heparan sulfate biosynthesis]
exostoses (multiple) 1,OMIM_DISEASE[520001004$Chondrosarcoma, 520001820$Exostoses, multiple, type 1, 520004915$trichorhinophalangeal syndrome, type II]
exostoses (multiple) 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000673$Hereditary multiple exostoses, 790000919$membrane, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane, 790001580$tumor suppressor]
exostoses (multiple) 1,UP_SEQ_FEATURE[850018286$chain:Exostosin-1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
glutamate receptor interacting protein 2,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
glutamate receptor interacting protein 2,SMART[760000200$SM00228:PDZ]
glutamate receptor interacting protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001304$repeat]
glutamate receptor interacting protein 2,UP_SEQ_FEATURE[850021577$chain:Glutamate receptor-interacting protein 2, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850104927$domain:PDZ 5, 850104928$domain:PDZ 6, 850104929$domain:PDZ 7, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
growth hormone 2,INTERPRO[450001245$IPR001400:Somatotropin hormone, 450011046$IPR012351:Four-helical cytokine, core, 450016416$IPR018116:Somatotropin hormone, conserved site]
growth hormone 2,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
growth hormone 2,PIR_SUPERFAMILY[630001964$PIRSF001825:prolactin/lactogen/growth hormone]
growth hormone 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000708$hormone, 790001189$placenta, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
growth hormone 2,UP_SEQ_FEATURE[850022468$chain:Growth hormone variant, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),INTERPRO[450001972$IPR002225:3-beta hydroxysteroid dehydrogenase/isomerase, 450002724$IPR003100:Argonaute and Dicer protein, PAZ, 450002783$IPR003165:Stem cell self-renewal protein Piwi, 450014426$IPR016040:NAD(P)-binding domain]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis, 470038847$hsa04320:Dorso-ventral axis formation]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),OMIM_DISEASE[520000990$Cholestasis, progressive familial intrahepatic 4]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),PIR_SUPERFAMILY[630028161$PIRSF036679:bifunctional 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase, 630029992$PIRSF038460:piwi protein]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000790$intrahepatic cholestasis, 790000915$meiosis, 790000919$membrane, 790000953$methylation, 790001006$nad, 790001077$oogenesis, 790001092$oxidoreductase, 790001212$polymorphism, 790001339$rna-binding, 790001342$rna-mediated gene silencing, 790001426$spermatogenesis, 790001444$steroidogenesis, 790001551$translation regulation, 790001555$transmembrane]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850001374$chain:3 beta-hydroxysteroid dehydrogenase type 7, 850039216$chain:Piwi-like protein 2, 850104911$domain:PAZ, 850105001$domain:Piwi, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
hydroxysteroid (11-beta) dehydrogenase 1-like,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
hydroxysteroid (11-beta) dehydrogenase 1-like,PIR_SUPERFAMILY[630000148$PIRSF000126:11beta-hydroxysteroid dehydrogenase]
hydroxysteroid (11-beta) dehydrogenase 1-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001008$nadp, 790001092$oxidoreductase, 790001363$Secreted, 790001405$signal]
hydroxysteroid (11-beta) dehydrogenase 1-like,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000555$binding site:Substrate, 850025270$chain:Hydroxysteroid 11-beta-dehydrogenase 1- like protein, 850106307$nucleotide phosphate-binding region:NADP, 850117814$signal peptide, 850118574$splice variant]
insulin-like 6,INTERPRO[450004307$IPR004825:Insulin/IGF/relaxin, 450015420$IPR017100:Insulin-like peptide 6]
insulin-like 6,PIR_SUPERFAMILY[630028563$PIRSF037062:insulin-like peptide 6, 630028564$PIRSF037062:Insulin-like_peptide_6]
insulin-like 6,SMART[760000068$SM00078:IlGF]
insulin-like 6,SP_PIR_KEYWORDS[790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000447$disulfide bond, 790000708$hormone, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
insulin-like 6,UP_SEQ_FEATURE[850026192$chain:Insulin-like peptide INSL6, 850102883$disulfide bond, 850107934$peptide:Insulin-like peptide INSL6 A chain, 850107935$peptide:Insulin-like peptide INSL6 B chain, 850109655$propeptide:Connecting peptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
integral membrane protein 2A,INTERPRO[450006473$IPR007084:BRICHOS]
integral membrane protein 2A,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
integral membrane protein 2A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
integral membrane protein 2A,UP_SEQ_FEATURE[850026207$chain:Integral membrane protein 2A, 850103162$domain:BRICHOS, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118623$transmembrane region]
interferon induced transmembrane protein 1 (9-27),INTERPRO[450006944$IPR007593:Interferon-induced transmembrane protein]
interferon induced transmembrane protein 1 (9-27),KEGG_PATHWAY[470038870$hsa04662:B cell receptor signaling pathway]
interferon induced transmembrane protein 1 (9-27),PIR_SUPERFAMILY[630013367$PIRSF016581:interferon-induced transmembrane protein]
interferon induced transmembrane protein 1 (9-27),SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
interferon induced transmembrane protein 1 (9-27),UP_SEQ_FEATURE[850026464$chain:Interferon-induced transmembrane protein 1, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
kininogen 1,BIOCARTA[30000165$h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway]
kininogen 1,INTERPRO[450000008$IPR000010:Proteinase inhibitor I25, cystatin, 450002128$IPR002395:HMW kininogen, 450016374$IPR018073:Proteinase inhibitor I25, cystatin, conserved site]
kininogen 1,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
kininogen 1,OMIM_DISEASE[520001913$Fitzgerald factor deficiency, 520002334$High molecular weight kininogen deficiency, 520002335$High-molecular-weight kininogen deficiency, 520002744$Kininogen deficiency]
kininogen 1,SMART[760000035$SM00043:CY]
kininogen 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000192$blood coagulation, 790000198$bradykinin, 790000356$complete proteome, 790000398$cysteine proteinase inhibitor, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000745$hydroxylation, 790000747$hydroxyproline, 790000775$inflammatory response, 790001162$phosphoprotein, 790001191$plasma, 790001212$polymorphism, 790001253$protease inhibitor, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat, 790001510$thiol protease inhibitor, 790001606$vasoactive, 790001608$vasodilator]
kininogen 1,UP_SEQ_FEATURE[850027560$chain:Kininogen-1, 850027561$chain:Kininogen-1 heavy chain, 850027562$chain:Kininogen-1 light chain, 850102540$compositionally biased region:His-rich, 850102883$disulfide bond, 850103469$domain:Cystatin 1, 850103470$domain:Cystatin 2, 850103471$domain:Cystatin 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850106258$modified residue, 850106774$peptide:Bradykinin, 850108110$peptide:Low molecular weight growth-promoting factor, 850108134$peptide:Lysyl-bradykinin, 850109303$peptide:T-kinin, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118073$site:Cleavage; by kallikrein, 850118450$site:Not glycosylated, 850118574$splice variant]
late cornified envelope 1C,INTERPRO[450002847$IPR003267:Small proline-rich]
late cornified envelope 1C,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization, 790001212$polymorphism]
late cornified envelope 1C,UP_SEQ_FEATURE[850028022$chain:Late cornified envelope protein 1C, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant]
lectin, galactoside-binding, soluble, 13,INTERPRO[450000945$IPR001079:Galectin, carbohydrate recognition domain, 450011956$IPR013320:Concanavalin A-like lectin/glucanase, subgroup]
lectin, galactoside-binding, soluble, 13,SMART[760000247$SM00276:GLECT]
lectin, galactoside-binding, soluble, 13,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000447$disulfide bond, 790000743$hydrolase, 790000848$Lectin, 790000869$lipid degradation, 790001382$serine esterase]
lectin, galactoside-binding, soluble, 13,UP_SEQ_FEATURE[850020422$chain:Galactoside-binding soluble lectin 13, 850104037$domain:Galectin, 850105852$helix, 850118575$strand, 850118624$turn]
lysophosphatidic acid receptor 5,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450002032$IPR002286:P2 purinoceptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
lysophosphatidic acid receptor 5,PIR_SUPERFAMILY[630030133$PIRSF038630:probable G protein-coupled receptor 92, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
lysophosphatidic acid receptor 5,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
lysophosphatidic acid receptor 5,UP_SEQ_FEATURE[850029343$chain:Lysophosphatidic acid receptor 5, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
membrane-spanning 4-domains, subfamily A, member 14,INTERPRO[450006606$IPR007237:CD20/IgE Fc receptor beta subunit]
membrane-spanning 4-domains, subfamily A, member 14,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001555$transmembrane]
membrane-spanning 4-domains, subfamily A, member 14,UP_SEQ_FEATURE[850031170$chain:Membrane-spanning 4-domains subfamily A member 14, 850102485$compositionally biased region:Gln-rich, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
mitochondrial ribosomal protein L55,INTERPRO[450016887$IPR018615:Ribosomal protein L55, mitochondrial]
mitochondrial ribosomal protein L55,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001550$transit peptide]
mitochondrial ribosomal protein L55,UP_SEQ_FEATURE[850001800$chain:39S ribosomal protein L55, mitochondrial, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
neuroguidin, EIF4E binding protein,INTERPRO[450006519$IPR007146:Sas10/Utp3/C1D]
neuroguidin, EIF4E binding protein,PIR_SUPERFAMILY[630023633$PIRSF031081:PIRSF031081]
neuroguidin, EIF4E binding protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001551$translation regulation]
neuroguidin, EIF4E binding protein,UP_SEQ_FEATURE[850033995$chain:Neuroguidin, 850106258$modified residue, 850113608$region of interest:Necessary for interaction with EIF4E, 850117295$sequence variant, 850118574$splice variant]
olfactory receptor, family 5, subfamily AN, member 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 5, subfamily AN, member 1,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 5, subfamily AN, member 1,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 5, subfamily AN, member 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 5, subfamily AN, member 1,UP_SEQ_FEATURE[850035860$chain:Olfactory receptor 5AN1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
pecanex-like 2 (Drosophila),INTERPRO[450007089$IPR007735:Pecanex, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
pecanex-like 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
pecanex-like 2 (Drosophila),UP_SEQ_FEATURE[850037002$chain:Pecanex-like protein 2, 850102597$compositionally biased region:Ser-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
phosphate regulating endopeptidase homolog, X-linked,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
phosphate regulating endopeptidase homolog, X-linked,INTERPRO[450000617$IPR000718:Peptidase M13, neprilysin, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450008005$IPR008753:Peptidase M13, 450014042$IPR015603:Phosphate Regulating Neutral Endopeptidase, 450016770$IPR018497:Peptidase M13, neprilysin, C-terminal]
phosphate regulating endopeptidase homolog, X-linked,OMIM_DISEASE[520002536$Hypophosphatemia, X-linked]
phosphate regulating endopeptidase homolog, X-linked,PIR_SUPERFAMILY[630001335$PIRSF001194:neprilysin-like metallopeptidases]
phosphate regulating endopeptidase homolog, X-linked,SP_PIR_KEYWORDS[790000069$Aminopeptidase, 790000183$biomineralization, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001252$Protease, 790001409$Signal-anchor, 790001555$transmembrane, 790001648$zinc]
phosphate regulating endopeptidase homolog, X-linked,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850038367$chain:Phosphate-regulating neutral endopeptidase, 850105770$glycosylation site:N-linked (GlcNAc...), 850106244$metal ion-binding site:Zinc; catalytic, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
pleckstrin homology domain interacting protein,INTERPRO[450001324$IPR001487:Bromodomain, 450001490$IPR001680:WD40 repeat, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450016644$IPR018359:Bromodomain, conserved site, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
pleckstrin homology domain interacting protein,SMART[760000267$SM00297:BROMO, 760000289$SM00320:WD40]
pleckstrin homology domain interacting protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000206$bromodomain, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
pleckstrin homology domain interacting protein,UP_SEQ_FEATURE[850038065$chain:PH-interacting protein, 850102554$compositionally biased region:Lys-rich, 850102572$compositionally biased region:Poly-Glu, 850103167$domain:Bromo 1, 850103168$domain:Bromo 2, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117294$sequence conflict, 850117295$sequence variant]
polymerase (RNA) mitochondrial (DNA directed),INTERPRO[450001854$IPR002092:DNA-directed RNA polymerase, bacteriophage type]
polymerase (RNA) mitochondrial (DNA directed),PIR_SUPERFAMILY[630000858$PIRSF000742:DNA-directed RNA polymerase, 630030651$PIRSF500430:mitochondrial DNA-directed RNA polymerase, metazoan type]
polymerase (RNA) mitochondrial (DNA directed),SP_PIR_KEYWORDS[790000356$complete proteome, 790000468$dna-directed rna polymerase, 790000969$mitochondrion, 790001064$nucleotidyltransferase, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001547$transferase, 790001550$transit peptide]
polymerase (RNA) mitochondrial (DNA directed),UP_SEQ_FEATURE[850016111$chain:DNA-directed RNA polymerase, mitochondrial, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
protocadherin 8,INTERPRO[450001884$IPR002126:Cadherin, 450011801$IPR013164:Cadherin, N-terminal, 450013932$IPR015491:Protocadherin 8]
protocadherin 8,SMART[760000099$SM00112:CA]
protocadherin 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
protocadherin 8,UP_SEQ_FEATURE[850048762$chain:Protocadherin-8, 850103211$domain:Cadherin 1, 850103222$domain:Cadherin 2, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
regulator of G-protein signaling 6,INTERPRO[450000294$IPR000342:Regulator of G protein signalling, 450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014319$IPR015898:G-protein, gamma-like subunit]
regulator of G-protein signaling 6,PIR_SUPERFAMILY[630028460$PIRSF036966:regulator of G protein signaling, RGS7 type]
regulator of G-protein signaling 6,SMART[760000041$SM00049:DEP, 760000196$SM00224:GGL, 760000285$SM00315:RGS]
regulator of G-protein signaling 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001408$Signal transduction inhibitor]
regulator of G-protein signaling 6,UP_SEQ_FEATURE[850057035$chain:Regulator of G-protein signaling 6, 850103515$domain:DEP, 850104021$domain:G protein gamma, 850105178$domain:RGS, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118624$turn]
regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,BIOCARTA[30000208$h_npcPathway:Mechanism of Protein Import into the Nucleus, 30000251$h_ranMSpathway:Role of Ran in mitotic spindle regulation, 30000252$h_ranPathway:Cycling of Ran in nucleocytoplasmic transport]
regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,COG_ONTOLOGY[90000026$Cell division and chromosome partitioning / Cytoskeleton]
regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,INTERPRO[450000351$IPR000408:Regulator of chromosome condensation, RCC1, 450008218$IPR009091:Regulator of chromosome condensation/beta-lactamase-inhibitor protein II]
regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000449$DNA binding, 790000641$guanine-nucleotide releasing factor, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001484$tandem repeat]
regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,UP_SEQ_FEATURE[850057014$chain:Regulator of chromosome condensation, 850105852$helix, 850106258$modified residue, 850116898$repeat:RCC1 1, 850116909$repeat:RCC1 2, 850116910$repeat:RCC1 3, 850116911$repeat:RCC1 4, 850116912$repeat:RCC1 5, 850116913$repeat:RCC1 6, 850116914$repeat:RCC1 7, 850118575$strand, 850118624$turn]
ribophorin II,INTERPRO[450008060$IPR008814:Ribophorin II]
ribophorin II,KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
ribophorin II,PIR_SUPERFAMILY[630015113$PIRSF018501:oligosaccharyltransferase, ribophorin II (Swp1p) subunit]
ribophorin II,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000811$isopeptide bond, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein, 790001592$ubl conjugation]
ribophorin II,UP_SEQ_FEATURE[850016265$chain:Dolichyl-diphosphooligosaccharide-- protein glycosyltransferase subunit 2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
serologically defined colon cancer antigen 8,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
serologically defined colon cancer antigen 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
serologically defined colon cancer antigen 8,UP_SEQ_FEATURE[850060239$chain:Serologically defined colon cancer antigen 8, 850102485$compositionally biased region:Gln-rich, 850114742$region of interest:Sufficient for homodimerization, 850117295$sequence variant, 850118574$splice variant]
signal transducer and activator of transcription 5B,BBID[10000069$48.mice_minus_JAKs_and_STATs]
signal transducer and activator of transcription 5B,INTERPRO[450000852$IPR000980:SH2 motif, 450001070$IPR001217:STAT transcription factor, core, 450010817$IPR011992:EF-Hand type, 450011041$IPR012345:STAT transcription factor, DNA-binding, subdomain, 450012408$IPR013799:STAT transcription factor, protein interaction, 450012409$IPR013800:STAT transcription factor, all-alpha, 450012410$IPR013801:STAT transcription factor, DNA-binding]
signal transducer and activator of transcription 5B,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038866$hsa04630:Jak-STAT signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038910$hsa05220:Chronic myeloid leukemia, 470038911$hsa05221:Acute myeloid leukemia]
signal transducer and activator of transcription 5B,OMIM_DISEASE[520002199$Growth hormone insensitivity with immunodeficiency, 520002851$Leukemia, acute promyelocytic, STAT5B/RARA type]
signal transducer and activator of transcription 5B,PIR_SUPERFAMILY[630012317$PIRSF015568:signal transducer and transcription activator STAT5A]
signal transducer and activator of transcription 5B,SMART[760000224$SM00252:SH2]
signal transducer and activator of transcription 5B,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain, 790001539$Transcription, 790001543$transcription regulation]
signal transducer and activator of transcription 5B,UP_SEQ_FEATURE[850060807$chain:Signal transducer and activator of transcription 5B, 850105346$domain:SH2, 850106258$modified residue, 850114367$region of interest:Required for interaction with NMI, 850117294$sequence conflict, 850117295$sequence variant]
similar to hCG1820375; PRP4 pre-mRNA processing factor 4 homolog B (yeast),INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
similar to hCG1820375; PRP4 pre-mRNA processing factor 4 homolog B (yeast),SMART[760000193$SM00220:S_TKc]
similar to hCG1820375; PRP4 pre-mRNA processing factor 4 homolog B (yeast),SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000988$mrna processing, 790000989$mrna splicing, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001433$Spliceosome, 790001547$transferase]
similar to hCG1820375; PRP4 pre-mRNA processing factor 4 homolog B (yeast),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059960$chain:Serine/threonine-protein kinase PRP4 homolog, 850102434$compositionally biased region:Arg/Lys-rich (basic), 850102540$compositionally biased region:His-rich, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,UP_SEQ_FEATURE[850031828$chain:Mitochondrial 2-oxodicarboxylate carrier, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117295$sequence variant, 850118623$transmembrane region]
solute carrier family 35, member F2,INTERPRO[450008372$IPR009262:Protein of unknown function DUF914, eukaryotic]
solute carrier family 35, member F2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
solute carrier family 35, member F2,UP_SEQ_FEATURE[850061447$chain:Solute carrier family 35 member F2, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
spermatid associated,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
spermatid associated,UP_SEQ_FEATURE[850061868$chain:Spermatid-associated protein, 850117295$sequence variant, 850118574$splice variant]
splA/ryanodine receptor domain and SOCS box containing 3,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY]
splA/ryanodine receptor domain and SOCS box containing 3,SMART[760000225$SM00253:SOCS]
splA/ryanodine receptor domain and SOCS box containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001301$receptor]
splA/ryanodine receptor domain and SOCS box containing 3,UP_SEQ_FEATURE[850062257$chain:SPRY domain-containing SOCS box protein 3, 850103078$domain:B30.2/SPRY, 850105375$domain:SOCS box, 850117294$sequence conflict, 850117295$sequence variant]
suppressor of cytokine signaling 2,INTERPRO[450000852$IPR000980:SH2 motif, 450001330$IPR001496:SOCS protein, C-terminal]
suppressor of cytokine signaling 2,KEGG_PATHWAY[470038866$hsa04630:Jak-STAT signaling pathway, 470038882$hsa04910:Insulin signaling pathway, 470038887$hsa04930:Type II diabetes mellitus]
suppressor of cytokine signaling 2,OMIM_DISEASE[520001993$Genome-wide association analysis identifies 20 loci that influence adult height, 520003072$Many sequence variants affecting diversity of adult human height]
suppressor of cytokine signaling 2,PIR_SUPERFAMILY[630006289$PIRSF006354:suppressor of cytokine signaling (SOCS) 1-3]
suppressor of cytokine signaling 2,SMART[760000224$SM00252:SH2, 760000225$SM00253:SOCS]
suppressor of cytokine signaling 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000635$growth regulation, 790001212$polymorphism, 790001397$SH2 domain, 790001408$Signal transduction inhibitor, 790001593$ubl conjugation pathway]
suppressor of cytokine signaling 2,UP_SEQ_FEATURE[850062984$chain:Suppressor of cytokine signaling 2, 850105346$domain:SH2, 850105375$domain:SOCS box, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
tetraspanin 16,BBID[10000086$66.Prot_Interac_w_integrin_domains]
tetraspanin 16,INTERPRO[450000259$IPR000301:Tetraspanin, subgroup, 450016772$IPR018499:Tetraspanin, 450016776$IPR018503:Tetraspanin, conserved site]
tetraspanin 16,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
tetraspanin 16,UP_SEQ_FEATURE[850063977$chain:Tetraspanin-16, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
transmembrane and ubiquitin-like domain containing 1,INTERPRO[450000534$IPR000626:Ubiquitin, 450018185$IPR019955:Ubiquitin supergroup]
transmembrane and ubiquitin-like domain containing 1,SMART[760000186$SM00213:UBQ]
transmembrane and ubiquitin-like domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001555$transmembrane]
transmembrane and ubiquitin-like domain containing 1,UP_SEQ_FEATURE[850065933$chain:Transmembrane and ubiquitin-like domain- containing protein 1, 850105602$domain:Ubiquitin-like, 850106258$modified residue, 850117605$short sequence motif:Nuclear export signal, 850118623$transmembrane region]
tripartite motif-containing 62,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001628$IPR001841:Zinc finger, RING-type, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003406$IPR003879:Butyrophylin-like, 450005994$IPR006574:SPRY-associated, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
tripartite motif-containing 62,SMART[760000158$SM00184:RING, 760000304$SM00336:BBOX, 760000524$SM00589:PRY]
tripartite motif-containing 62,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001648$zinc, 790001651$zinc-finger]
tripartite motif-containing 62,UP_SEQ_FEATURE[850066665$chain:Tripartite motif-containing protein 62, 850103078$domain:B30.2/SPRY, 850117294$sequence conflict, 850118638$zinc finger region:B box-type, 850118911$zinc finger region:RING-type]
two pore segment channel 1,INTERPRO[450005268$IPR005821:Ion transport]
two pore segment channel 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000344$coiled coil, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001304$repeat, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
two pore segment channel 1,UP_SEQ_FEATURE[850067305$chain:Two pore calcium channel protein 1, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-conjugating enzyme E2D 3 pseudogene,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-conjugating enzyme E2D 3 pseudogene,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-conjugating enzyme E2D 3 pseudogene,SMART[760000185$SM00212:UBCc]
ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-conjugating enzyme E2D 3 pseudogene,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000859$ligase, 790001063$nucleotide-binding, 790001593$ubl conjugation pathway]
ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast); ubiquitin-conjugating enzyme E2D 3 pseudogene,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068083$chain:Ubiquitin-conjugating enzyme E2 D3, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
zinc finger and BTB domain containing 25,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006475$IPR007087:Zinc finger, C2H2-type, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger and BTB domain containing 25,SMART[760000197$SM00225:BTB, 760000323$SM00355:ZnF_C2H2]
zinc finger and BTB domain containing 25,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger and BTB domain containing 25,UP_SEQ_FEATURE[850101235$chain:Zinc finger and BTB domain-containing protein 25, 850103177$domain:BTB, 850117294$sequence conflict, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2]
zinc finger protein 204 pseudogene,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 204 pseudogene,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger, DHHC-type containing 16,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger, DHHC-type containing 16,INTERPRO[450001416$IPR001594:Zinc finger, DHHC-type]
zinc finger, DHHC-type containing 16,PIR_SUPERFAMILY[630029028$PIRSF037459:zinc finger DHHC domain-containing protein 7]
zinc finger, DHHC-type containing 16,SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790000937$metal-binding, 790001547$transferase, 790001555$transmembrane, 790001648$zinc, 790001651$zinc-finger]
zinc finger, DHHC-type containing 16,UP_SEQ_FEATURE[850043048$chain:Probable palmitoyltransferase ZDHHC16, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region, 850118801$zinc finger region:DHHC-type]
